ClinicalTrials HQ

A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)

A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)

Active, not recruiting · NCT06496178 · Registry updated 2026-09-25
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinomaActive, not recruitingPhase 32026-09-25NCT06496178

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Merus B.V.4

194 results · Page 1 of 8

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Site 1JerusalemIsrael1
Site 10BlacksburgUnited States1
Site 100New OrleansUnited States1
Site 102PrescottUnited States1
Site 103Ann ArborUnited States1
Site 104Washington D.C.United States1
Site 105BordeauxFrance1
Site 106MontpellierFrance1
Site 107RouenFrance1
Site 108LiègeBelgium1
Site 109MadridSpain1
Site 11Saint LeonardsAustralia1
Site 110RosarioArgentina1
Site 111CuneoItaly1
Site 112HanoverGermany1
Site 113VillejuifFrance1
Site 114ParisFrance1
Site 115MarseilleFrance1
Site 116LeipzigGermany1
Site 117PoznanPoland1
Site 118LyonFrance1
Site 119ToulouseFrance1
Site 12Fort MyersUnited States1
Site 120HeraklionGreece1
Site 121BerlinGermany1